Literature DB >> 15048922

Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors?

P Walczak1, N Chen, J E Hudson, A E Willing, S N Garbuzova-Davis, S Song, P R Sanberg, J Sanchez-Ramos, P C Bickford, T Zigova.   

Abstract

Hematopoietic progenitors are cells, which under challenging experimental conditions can develop unusual phenotypic properties, rather distant from their original mesodermal origin. As previously reported, cells derived from human umbilical cord blood (HUCB) or human bone marrow (BM) under certain in vivo or in vitro conditions can manifest neural features that resemble features of neural-derived cells, immunocytochemically and in some instances also morphologically. The present study explored how hematopoietic-derived cells would respond to neurogenic signals from the subventricular zone (SVZ) of adult and aged (6 and 16 months old) rats. The mononuclear fraction of HUCB cells was transplanted into the SVZ of immunosuppressed (single cyclosporin or three-drug treatment) animals. The triple-suppression paradigm allowed us to protect transplanted human cells within the brain and to explore further their phenotypic and migratory properties. One week after implantation, many surviving HUCB cells were located within the SVZ and the vertical limb of the rostral migratory stream (RMS). The migration of HUCB cells was restricted exclusively to the pathway leading to the olfactory bulb. In younger animals, grafted cells navigated almost halfway through the vertical limb, whereas, in the older animals, the migration was less pronounced. The overall cell survival was greater in younger animals than in older ones. Immunocytochemistry for surface CD antigen expression showed that many HUCB cells, either cultured or within the brain parenchyma, retained their hematopoietic identity. A few cells, identified by using human-specific antibodies (anti-human nuclei, or mitochondria) expressed nestin and doublecortin, markers of endogenous neural progenitors. Therefore, it is believed that the environment of the neurogenic SVZ, even in aged animals, was able to support survival, "neuralization," and migratory features of HUCB-derived cells. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048922      PMCID: PMC1702369          DOI: 10.1002/jnr.20042

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  48 in total

1.  Human umbilical cord cells: a new cell source for cardiovascular tissue engineering.

Authors:  Alexander Kadner; Simon P Hoerstrup; Jay Tracy; Christian Breymann; Christine F Maurus; Serguei Melnitchouk; Gregor Kadner; Gregor Zund; Marko Turina
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

2.  Triple immunosuppression protects murine intracerebral, hippocampal xenografts in adult rat hosts: effects on cellular infiltration, major histocompatibility complex antigen induction and blood-brain barrier leakage.

Authors:  E B Pedersen; J Zimmer; B Finsen
Journal:  Neuroscience       Date:  1997-06       Impact factor: 3.590

3.  Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro.

Authors:  Hsiao-Nan Hao; Jane Zhao; Ronald L Thomas; Graham C Parker; William D Lyman
Journal:  J Hematother Stem Cell Res       Date:  2003-02

4.  Adult bone marrow stromal cells differentiate into neural cells in vitro.

Authors:  J Sanchez-Ramos; S Song; F Cardozo-Pelaez; C Hazzi; T Stedeford; A Willing; T B Freeman; S Saporta; W Janssen; N Patel; D R Cooper; P R Sanberg
Journal:  Exp Neurol       Date:  2000-08       Impact factor: 5.330

5.  Isolation of multipotent adult stem cells from the dermis of mammalian skin.

Authors:  J G Toma; M Akhavan; K J Fernandes; F Barnabé-Heider; A Sadikot; D R Kaplan; F D Miller
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

6.  Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation.

Authors:  Svitlana Garbuzova-Davis; Alison E Willing; Tanja Zigova; Samuel Saporta; Eleanor B Justen; Jennifer C Lane; Jennifer E Hudson; Ning Chen; Cyndy D Davis; Paul R Sanberg
Journal:  J Hematother Stem Cell Res       Date:  2003-06

7.  Human umbilical cord blood cells can be induced to express markers for neurons and glia.

Authors:  Alma R Bicknese; Holly S Goodwin; Cheryl O Quinn; Verneake C D Henderson; Shin-Nan Chien; Donna A Wall
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

8.  Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain.

Authors:  Tanja Zigova; Shijie Song; Alison E Willing; Jennifer E Hudson; Mary B Newman; Samuel Saporta; Juan Sanchez-Ramos; Paul R Sanberg
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

9.  Human cord blood-derived cells attain neuronal and glial features in vitro.

Authors:  L Buzańska; E K Machaj; B Zabłocka; Z Pojda; K Domańska-Janik
Journal:  J Cell Sci       Date:  2002-05-15       Impact factor: 5.285

Review 10.  Is transdifferentiation in trouble?

Authors:  William A Wells
Journal:  J Cell Biol       Date:  2002-03-26       Impact factor: 10.539

View more
  9 in total

1.  Ensheathing cell-conditioned medium directs the differentiation of human umbilical cord blood cells into aldynoglial phenotype cells.

Authors:  María Dolores Ponce-Regalado; Daniel Ortuño-Sahagún; Carlos Beas Zarate; Graciela Gudiño-Cabrera
Journal:  Hum Cell       Date:  2012-04-21       Impact factor: 4.174

2.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

3.  Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia.

Authors:  Piotr Walczak; Jian Zhang; Assaf A Gilad; Dorota A Kedziorek; Jesus Ruiz-Cabello; Randell G Young; Mark F Pittenger; Peter C M van Zijl; Judy Huang; Jeff W M Bulte
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

4.  Cellular environment directs differentiation of human umbilical cord blood-derived neural stem cells in vitro.

Authors:  Inga Markiewicz; Joanna Sypecka; Krystyna Domanska-Janik; Tomasz Wyszomirski; Barbara Lukomska
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

5.  The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study.

Authors:  Alok K Sharma; Hemangi M Sane; Amruta A Paranjape; Nandini Gokulchandran; Anjana Nagrajan; Myola D'sa; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2015-03-15

6.  Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural.

Authors:  Ning Chen; Jennifer E Hudson; Piotr Walczak; Iwona Misiuta; Svitlana Garbuzova-Davis; Lixian Jiang; Juan Sanchez-Ramos; Paul R Sanberg; Tanja Zigova; Alison E Willing
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

7.  Neonatal desensitization does not universally prevent xenograft rejection.

Authors:  Miroslaw Janowski; Anna Jablonska; Hanna Kozlowska; Inema Orukari; Segun Bernard; Jeff W M Bulte; Barbara Lukomska; Piotr Walczak
Journal:  Nat Methods       Date:  2012-09       Impact factor: 28.547

8.  Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice.

Authors:  Piotr Walczak; Ning Chen; David Eve; Jennifer Hudson; Tanja Zigova; Juan Sanchez-Ramos; Paul R Sanberg; Cyndy D Sanberg; Alison E Willing
Journal:  Brain Res Bull       Date:  2007-07-10       Impact factor: 4.077

9.  Trophic factors and stem cells for promoting recovery in stroke.

Authors:  Guven Uzun; Dawood Subhani; Srikureja Amor
Journal:  J Vasc Interv Neurol       Date:  2010-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.